Breast Cancer Risk Calculator (Gail Model)
This calculator uses the Gail Model (Breast Cancer Risk Assessment Tool), the evidence-based method developed by the National Cancer Institute, to estimate your personal risk of developing invasive breast cancer over the next 5 years and over your lifetime. Enter your age, race, reproductive history, and biopsy history to see how your risk compares to the average for women your age. A 5-year risk above 1.67% meets the FDA threshold used to discuss preventive options with a doctor.
What is the Gail Model?
The Gail Model, also called the Breast Cancer Risk Assessment Tool (BCRAT), was developed in 1989 by Dr. Mitchell Gail and colleagues at the National Cancer Institute. It estimates the absolute probability that a woman will develop invasive breast cancer over a defined period, typically the next 5 years and over her remaining lifetime to age 90. The model combines seven risk factors: current age, age at first menstrual period, age at first live birth, number of first-degree relatives diagnosed with breast cancer, number of previous benign breast biopsies, atypical hyperplasia found on biopsy, and race/ethnicity. It is the most widely validated breast cancer risk model and is used in clinical practice to identify women who may benefit from chemoprevention or enhanced surveillance.
How is the 5-year risk calculated?
The model works in two stages. First, it computes a relative risk (RR) by multiplying four categorical coefficients: one for menarche age, one for biopsy history (adjusted for age above or below 50), one for atypical hyperplasia status, and one from a two-way matrix combining first live birth age and family history count. This RR represents how many times higher your risk is compared with an average woman of the same age and race. Second, it applies that relative risk to the age- and race-specific baseline breast cancer incidence rate to produce an absolute percentage risk. For example, if the baseline 5-year risk for a 45-year-old White woman is about 1.35% and your relative risk is 2.0, your estimated 5-year risk is roughly 2.7%.
What do the results mean?
The FDA threshold most often used in clinical practice is a 5-year absolute risk of 1.67%. Women at or above this threshold are considered candidates for risk-reducing (chemopreventive) medications such as tamoxifen, raloxifene, or aromatase inhibitors, which have been shown to lower breast cancer incidence by 30 to 50 percent in high-risk women. A result below 1.67% does not mean you are immune: it means your estimated risk is close to or below the population average. Regular mammography screening is still important regardless of your Gail score. A result at or above 3.0% is generally classified as high risk and warrants a conversation with your provider about additional imaging such as breast MRI, referral to a genetics counselor, or preventive medication.
Limitations of the Gail Model
The Gail model intentionally focuses on a handful of well-validated risk factors that are easy to collect in a clinical setting. It does not account for BRCA1 or BRCA2 mutations, second-degree relatives (grandmothers, aunts, cousins), paternal family history, breast density, prior radiation to the chest, hormone replacement therapy use, alcohol consumption, obesity after menopause, or personal history of DCIS or LCIS. Because it uses only first-degree relatives, it may substantially underestimate risk in women with strong hereditary patterns. It was primarily validated in US White women and may be less accurate in other populations, tending to underestimate risk in Black women with a history of biopsies. Women with known BRCA mutations, a history of DCIS or LCIS, or a strong family history spanning multiple generations should use a more comprehensive model such as Tyrer-Cuzick (IBIS) or BOADICEA, or be referred to a hereditary cancer risk program.
Breast cancer risk categories by 5-year absolute risk
| 5-year risk | Category | Typical guidance |
|---|---|---|
| Below 1.67% | Average or below average | Routine screening |
| 1.67% to 2.99% | Above average | Discuss with provider; preventive options may apply |
| 3.0% or higher | High | Consider risk-reducing medications and enhanced screening |
FDA and NCI thresholds used to guide chemoprevention discussions.
Frequently asked questions
Who should use the Gail Model calculator?
The Gail Model is designed for women aged 20 to 84 who have no personal history of invasive breast cancer, ductal carcinoma in situ (DCIS), or lobular carcinoma in situ (LCIS), and who do not have a known BRCA1 or BRCA2 mutation. It is best suited for women with an unremarkable or moderately elevated family history. Those with extensive family histories of breast or ovarian cancer on either side of the family, or with a personal history of these conditions, should be evaluated with a more comprehensive model.
What is the 1.67% threshold?
The U.S. Food and Drug Administration uses a 5-year absolute risk of 1.67% as the threshold for approving risk-reducing medications in women with no breast cancer history. It was chosen because it represents roughly the average 5-year risk of a 60-year-old White woman. Being at or above this threshold is not a diagnosis and does not mean cancer is inevitable: it means evidence-based preventive options may be worth discussing with your doctor.
Does the model work for women younger than 35?
The original Gail model was validated primarily in women aged 35 and older. NCI now allows input from age 20 onward, but 5-year absolute risks in younger women are inherently very small, and the model is less well calibrated below 35. For most women under 35, clinical assessment and family history review are more useful than a formal risk score.
Can I use this tool if I have BRCA mutations?
No. The Gail Model was developed before BRCA testing was routine and does not include genetic factors. Women with known BRCA1 or BRCA2 mutations have a lifetime risk often exceeding 60-80%, which the Gail Model would dramatically underestimate. Mutation carriers should be managed under dedicated hereditary breast and ovarian cancer (HBOC) protocols.
Does a low Gail score mean I do not need mammograms?
No. A low 5-year risk estimate from the Gail Model means your risk is close to or below the population average for your age, but population-average risk still means some women develop breast cancer. Major guidelines, including those from the American Cancer Society and the U.S. Preventive Services Task Force, recommend regular mammography for average-risk women starting between ages 40 and 50, depending on individual preference and provider recommendation.
What is relative risk versus absolute risk?
Relative risk (RR) is a ratio: how much higher your risk is compared with an average woman of the same age and race. An RR of 2.0 means twice the average risk. Absolute risk is the actual percentage probability of developing breast cancer in a given time window, for example 2.7% over 5 years. Absolute risk is more clinically useful because it tells you the actual likelihood, whereas relative risk can sound alarming even when the underlying absolute number is small.